MSL
GBT

Mackay Shields LLC’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Mackay Shields LLC’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-13,200
Closed -$834K – 1589
2020
Q2 		$834K Sell
13,200
-25,037
-65% -$1.72M 0.01% 1079
2020
Q1 		$1.95M Sell
38,237
-4,000
-9% -$268K 0.02% 677
2019
Q4 		$3.36M Sell
42,237
-2,400
-5% -$142K 0.02% 662
2019
Q3 		$2.17M Buy
44,637
+1,200
+3% +$62.5K 0.01% 866
2019
Q2 		$2.29M Buy
43,437
+27,554
+173% +$1.58M 0.02% 847
2019
Q1 		$840K Sell
15,883
-600
-4% -$29.5K 0.01% 1051
2018
Q4 		$677K Sell
16,483
-1,717
-9% -$64.3K 0.01% 1062
2018
Q3 		$692K Buy
18,200
+2,500
+16% +$111K 0.01% 952
2018
Q2 		$710K Buy
15,700
+600
+4% +$27.3K ﹤0.01% 1029
2018
Q1 		$729K Buy
+15,100
New +$842K ﹤0.01% 1058

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackay Shields LLC's GBT Position: Q3 2020 in Review

Mackay Shields LLC sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2020, closing a stake of 13,200 shares — an estimated $834K sold.

Mackay Shields LLC first reported a position in GBT in Q1 2018 and held it in 10 quarters. The position peaked at $3.36M in Q4 2019. 229 funds tracked by Wall St. Rank hold GBT as of Q3 2020.

  • Mackay Shields LLC reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
  • Mackay Shields LLC sold 13,200 Global Blood Therapeutics, Inc. shares in Q3 2020, an estimated $834K.
  • Mackay Shields LLC first reported a position in Global Blood Therapeutics, Inc. in Q1 2018 and held it in 10 quarters.
  • Mackay Shields LLC's Global Blood Therapeutics, Inc. position peaked at $3.36M in Q4 2019.
  • 229 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2020.

Based on Mackay Shields LLC's 13F filing for Q3 2020, filed 4 Nov 2020.